🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Intellia Tx releases followup data for their ongoing HAE program, Lonvo-z. Attack-free for median of 23 months & 98% mean reduction of of monthly attacks... What else can they do to have folks realize the potential of in-vivo CRISPR? $NTLA Find out here: youtu.be/KzRusTDvRY4

Robotaxi one week out

CRISPR is here to move humanity forward.

Pakistan’s Bitcoin immersion is remarkable.🇵🇰💚

Remember the people who said CASGEVY $CRSP would get denied by the FDA in 2023? Yeah I don’t either. Be remembered or forgotten, chose wisely.

Be remembered, or be forgotten. Chose wisely.

CRISPR is going to become mainstream. Do you agree?

Bet against Tesla? Think again.

Fear comes from inexperience, not incapability.

Strategy has acquired 10,100 BTC for ~$1.05 billion at ~$104,080 per bitcoin and has achieved BTC Yield of 19.1% YTD 2025. As of 6/15/2025, we hodl 592,100 $BTC acquired for ~$41.84 billion at ~$70,666 per bitcoin. $MSTR $STRK $STRF $STRD strategy.com/press/strategy…

Pakistan has officially named Michael Saylor as their Bitcoin advisor.

$NTLA up 8%+ today. Expect more in the coming future.

Do your own research. Study so hard that people think you’re crazy. Then execute, and let it play out.

Diamond hands.

BREAKING! Eli Lilly $LLY buys Verve Therapeutics $VERV. This marks as the first publicly traded CRISPR company to sell out during the long bear market for biotech.

If $VERV can sell for $1.3B (nearly 3x their current valuation with no near FDA approval program), then $CRSP CRISPR Tx would sell for $20B+ easily. If you disagree, let me know.

I just became more bullish about CRISPR after today’s news. Valuation of CRISPR companies increased overnight, and I forsee big pharma pouring $ Billions into partnering with CRISPR companies.

If CRISPR wasn’t going anywhere, then why would Eli Lilly buy a 3x premium for a CRISPR company with only one phase 1b trial?